Skip to main content
. 2020 Sep 4;10:1690. doi: 10.3389/fonc.2020.01690

TABLE 3.

First-year survival percentages and MST of pancreas hyperthermia treatments (capacitive, 13.56 MHz).

Additive therapy AII Far-advanced diseased (%) No response on conventional (%) Operated (bypass or resected) (%) Median survival time (MST) (m)
Immune stimulation 35 13.3 34.1 48.7 8
No immune stimulation 6 0 0 11.1 6